All
How to cope when Mama Bear has cancer
Finding courage beneath the sword
Wider biomarker testing warranted in colorectal cancer
Chemobrain and late effects of childhood cancer
Federal funding for cancer research: The good, the bad and the ugly
More bad news for smoking
Dying online
Whatever it takes
Top Five Advances in TNBC Research in 2013
A place of tranquility and innocence
Top 10 CURE blogs of 2013
Australia continued...
Australia
Our journey to Australia
From ASH: Thanks for the memories
Cancer can't stop me from dreaming big
Mylotarg Reduces Risk of Relapse for Children with AML
Lung Cancer Drug Improves Survival in Patients with ALK-Positive Lymphoma
Xalkori improves survival in patients with ALK-positive lymphoma.
An advocate's experience during the San Antonio Breast Cancer Symposium
Focus on how well patients live instead of how long
For Kids Facing Cancer, Treatment Goals May Help with Coping
Goals and milestone recognitions may help children with cancer get through treatment a little easier.
Study Suggests Early Response to HER2-Positive Breast Cancer Therapy Could Equal Survival Advantage
Clinical trial results suggests that pathologic complete response after HER2-positive therapy equates to great survival.
Small Yet Significant Steps in Treating Triple-Negative Breast Cancer
Prevention Study Focuses on Anti-Hormone Therapy
Aromatase inhibitors may help prevent breast cancer.
Exercise Improves Joint Pain Related to Aromatase Inhibitors
When it comes to relieving joint pain from aromatase inhibitors, motion is lotion.
Metastatic disease demanding more attention
SABCS: Advances in hormone therapies for ER-positive breast cancer
Inflammatory breast cancer survivor advocates for education and research dollars
Newly Approved Gazyva May Become Standard in Older, Sicker Patients with Chronic Lymphocytic Leukemia
Gazyva may become a standard treatment for older, sicker patient with CLL.
Patients with Newly Diagnosed Myeloma Fare Better with Continuous Revlimid and Low-Dose Dexamethasone
Patients with multiple myeloma fare better with continuous Revlimid (lenalidomide).
